| Patents for C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120) |
|---|
| 07/24/2001 | US6265127 1, 4-dihydrophyridine charge control agents for electrostatographic toners and developers |
| 07/11/2001 | EP1015461A4 Novel compounds for generating chemiluminescence with a peroxidase |
| 07/11/2001 | CN1302804A Dihydrofuro [3,4-b] quinoline-1-ketone type compound, its preparation method and medicinal composition containing these compounds |
| 07/05/2001 | WO2001047899A1 Substituted piperazine derivatives as mtp inhibitors |
| 07/05/2001 | DE19963235A1 Substituierte Piperazinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel Substituted piperazine derivatives, their preparation and their use as medicaments |
| 07/05/2001 | CA2394644A1 Substituted piperazine derivatives,the preparation thereof and their useas medicaments |
| 07/04/2001 | EP1112257A1 Method for producing 3,6-diaminoacridine or its monohydrochloride |
| 07/04/2001 | EP1019379A4 Peroxide-based chemiluminescent assays and chemiluminescent compounds used therein |
| 07/03/2001 | CA2213317C Chemiluminescent compositions for reaction with phosphatase enzymes, and methods of use |
| 06/27/2001 | CN1301154A Amide derivatives and nociceptin antagonists |
| 06/20/2001 | EP1109070A2 1,4-Dihydropyridine charge control agents for electrostatographic toners and developers |
| 06/20/2001 | EP0890176B1 Proton conductor in liquid form |
| 06/19/2001 | US6248750 9-hydroxyamino tetrahydroacridine and related compounds |
| 06/14/2001 | WO2001041773A1 Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins |
| 06/14/2001 | WO2001009372B1 Chemiluminescent substrates of hydrolytic enzymes such as phosphatases |
| 06/13/2001 | CN1299345A Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds |
| 06/12/2001 | US6245775 Anticholesterol agents; cardiovascular disorders |
| 06/06/2001 | EP1104405A1 Near infrared chemiluminescent acridinium compounds and uses thereof |
| 06/05/2001 | US6242459 Substituted bis-acridines and related compounds as CCR5 receptor ligands, anti-inflammatory agents and anti-viral agents |
| 05/31/2001 | WO2001037826A1 Npyy5 antagonists |
| 05/30/2001 | EP1103554A1 Derivatives of dihydrofuro-(3,4-b)-quinolein-1-ones, process of préparation and phamaceutical compositions containing them |
| 05/30/2001 | EP0665834B1 Quinolone and acridinone derivatives for the treatment of urinary incontinence |
| 05/29/2001 | CA2003023C Hydroxy-1,2,3,4-tetrahydroaminoacridines, a process for their preparation and their use as medicaments |
| 05/17/2001 | WO2001035103A1 Stabilizing a luminescent acridinium compound |
| 05/16/2001 | EP1098864A1 Method for hydrogenating unsaturated heterocyclic compounds |
| 05/08/2001 | US6228942 Dehydration to esterify or amidate surface of oxidized or aminated carbon powder or fiber suspended in solution containing a monomer or polymer having amine, hydroxy, and/or viny ether groups |
| 05/02/2001 | EP1095011A1 Novel fluorescent lanthanide chelates |
| 05/01/2001 | US6225334 Glyoxylic acid derivatives |
| 04/18/2001 | EP1091942A1 Potassium channel blocking agents |
| 04/17/2001 | US6218137 Compounds, compositions and methods for generating chemiluminescene with phosphatase enzymes |
| 04/11/2001 | CN1291189A 9-aminoacridine derivatives and process for the preparation thereof |
| 04/05/2001 | WO2001023497A1 Organic electroluminescent element |
| 04/05/2001 | WO2000066782A3 Diagnostic assay for diabetes mellitus based on mutational burden |
| 03/28/2001 | CN1288893A Tacrine derivative for treatment of senlie dementia |
| 03/21/2001 | EP1085011A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 03/15/2001 | WO2001017529A1 Tacrine derivatives for treating alzheimer's disease |
| 03/15/2001 | CA2382706A1 Tacrine derivatives for treating alzheimer's disease |
| 03/15/2001 | CA2318004A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 03/06/2001 | US6197825 Azulenyl nitrone spin trapping agents, methods of making and using same |
| 02/27/2001 | US6194447 Bis (benzimidazole) derivatives serving as potassium blocking agents |
| 02/27/2001 | US6194424 Arylacetamides and their use as medicaments |
| 02/27/2001 | US6194403 Alpha, omega-bis-(6-chloro)tacrinyl-alkane, for example; a more selective acetylcholinesterase inhibitor; potentiation; side effects reduction |
| 02/22/2001 | WO2001012584A2 Pharmaceutical compounds |
| 02/22/2001 | CA2698353A1 Pharmaceutical compounds |
| 02/22/2001 | CA2381409A1 Nitric ester derivatives |
| 02/21/2001 | EP1076646A1 Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds |
| 02/21/2001 | EP0755457B1 Novel Aryl-N-Alkylacridanthiocarboxylate derivatives useful for chemiluminescent detection |
| 02/21/2001 | CN1284897A Batch devices for reduction of compounds from biological compositions containing cells and methods of use |
| 02/21/2001 | CN1284896A Flow device for the reduction of compounds from biological compositions and methods of use |
| 02/20/2001 | US6191140 Potassium channel modulators; muscle relaxants; controlling cell membranes |
| 02/13/2001 | US6187787 Bis(9-aminoacridine) DNA intercalating agents having antitumor activity |
| 02/13/2001 | US6187775 Acridone-derived compounds useful as antineoplastic and antiretroviral agents |
| 02/08/2001 | WO2001009372A1 Chemiluminescent substrates of hydrolytic enzymes such as phosphatases |
| 02/08/2001 | WO2000066528A3 Quinones for treatment of diseases |
| 01/31/2001 | EP1072263A1 Amide derivatives and nociceptin antagonists |
| 01/25/2001 | WO2000066587A3 Polyamines and their use in therapy |
| 01/23/2001 | CA2019717C (1,2,3,4-tetrahydro-9-acridinimino)cyclohexane carboxylic acid and related compounds, a process for their preparation and their use as medicaments |
| 01/09/2001 | US6172261 Biosynthesis using chain extension |
| 01/09/2001 | US6171859 Defective cytochrome c oxidase; diagnosing alzheimer*s disease |
| 01/09/2001 | US6171777 Decontaminating by contacting with compound, then recovering product; deactivates human immunodeficiency and hepatitis viruses; before transfusions or clinical tests |
| 01/09/2001 | US6171522 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials |
| 12/27/2000 | EP1062207A1 9-aminoacridine derivatives and process for the preparation thereof |
| 12/21/2000 | WO2000076982A1 Antagonism of immunostimulatory cpg-oligonucleotides by 4-aminoquinolines and other weak bases |
| 12/21/2000 | CA2412345A1 Antagonism of immunostimulatory cpg-oligonucleotides by 4-aminoquinolines and other weak bases |
| 12/19/2000 | US6162918 Tetramethylacridinedione derivatives are inhibitors of herpes simplex virus thymidine kinase in the treatment and prophylaxis of infections caused by herpes simplex virus. |
| 12/19/2000 | US6162610 Xanthan-ester and acridan substrates for horseradish peroxidase |
| 12/14/2000 | WO2000046187A3 Antizyme modulators and their use |
| 11/21/2000 | US6149215 Durable slings for vehicle frame turnover machines and method of making the slings |
| 11/14/2000 | US6146831 Cellular models for diabetes and other diseases associated with mitochondrial defects |
| 11/09/2000 | WO2000066782A2 Diagnostic assay for diabetes mellitus based on mutational burden |
| 11/09/2000 | WO2000066587A2 Polyamines and their use in therapy |
| 11/09/2000 | WO2000066528A2 Quinones for treatment of diseases |
| 11/09/2000 | WO2000066175A2 Conjugates as therapies for cancer and prostate diseases |
| 11/09/2000 | CA2372611A1 Quinones for treatment of diseases |
| 11/09/2000 | CA2368801A1 Conjugates as therapies for cancer and prostate diseases |
| 11/08/2000 | EP1049933A1 Measurement of hydride using chemiluminescent acridinium compounds |
| 11/07/2000 | US6143490 In vitro method for deactivation of viral, bacterial, or protozoan pathogen by adding compound consisting of intercalator nucleic acid binding ligand and an attached mustard group, treating the mixture, and recovering blood |
| 11/02/2000 | WO2000064864A1 N-protected amines and their use as prodrugs |
| 11/02/2000 | CA2368205A1 N-protected amines and their use as prodrugs |
| 10/31/2000 | US6139782 Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes |
| 10/19/2000 | WO2000061541A2 Pharmaceutical compounds |
| 10/19/2000 | WO2000061537A2 Pharmaceutical compounds |
| 10/19/2000 | CA2370425A1 Pharmaceutical compounds |
| 10/18/2000 | EP1044066A1 Batch devices for the reduction of compounds from biological compositions containing cells and methods of use |
| 10/10/2000 | US6130228 Alzheimers |
| 10/03/2000 | US6126870 Chemiluminescent labeling compounds |
| 09/27/2000 | EP0938677A4 Chemiluminescent detection methods using dual enzyme-labeled binding partners |
| 09/19/2000 | US6120696 Proton conductors in liquid form |
| 09/05/2000 | US6114332 Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumor agents |
| 08/29/2000 | US6111109 Cyclizing a 2-(2-alkyloxycarbonylphenyl)amino-)benzaldehyde by treating with a boron trifluoride; neutralization of the formed salt; amidation with an 2-n,n-dialkylaminoethylamine;antitumor and -carcinogenic |
| 08/23/2000 | EP1029016A1 Novel chemiluminescent labeling compounds |
| 08/10/2000 | WO2000046187A2 Antizyme modulators and their use |
| 08/10/2000 | CA2362259A1 Antizyme modulators and their use |
| 08/09/2000 | EP1026156A2 Novel 10, 10'-substituted-9,9'-biacridine luminescent molecules and their preparation |
| 08/03/2000 | WO2000032175A3 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY |
| 08/01/2000 | CA2019335C Phenylalkan (en)oic acids |
| 07/26/2000 | EP1021414A1 Frangible compounds for pathogen inactivation |
| 07/25/2000 | US6093725 Frangible compounds for pathogen inactivation |
| 07/19/2000 | EP1019379A1 Peroxide-based chemiluminescent assays and chemiluminescent compounds used therein |
| 07/18/2000 | US6090571 Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes |